Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2012: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2011: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
|
Research Abstract |
In this study, we confirmed that co-stimulatory molecule OX-40 plays pivotal role in inducing strong anti-tumor efficacy. Using OX-40 agonistic antibody, immunostimulatory effect was evaluated. Induction of anti-tumor effect was strongest when OX-40 signal was activated together with subcutaneous tumor vaccination. Thus, we tried to develop new immunotherapeutic strategy against glioblastoma. Activation of OX-40 signaling can be promising immunotherapy for glioblastoma.
|